CHRONIC GRANULOMATOUS DISEASE (CGD)
Clinical trials for CHRONIC GRANULOMATOUS DISEASE (CGD) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRANULOMATOUS DISEASE (CGD) trials appear
Sign up with your email to follow new studies for CHRONIC GRANULOMATOUS DISEASE (CGD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene-Editing breakthrough aims to fix immune cells in rare disease
Disease control Recruiting nowThis early-stage trial tests a new gene-editing technique (base editing) to repair a specific genetic mutation in people with X-linked chronic granulomatous disease (X-CGD), a rare immune disorder. Up to 10 adults will have their own blood stem cells collected, edited in a lab, a…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New study probes immune system clues in rare disease patients
Knowledge-focused Recruiting nowThis study measures levels of adenovirus-fighting antibodies and inflammatory markers in the blood of 60 adults and children with chronic granulomatous disease (CGD). The goal is to better understand the immune response in CGD, which may help design future treatments. Participant…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Sponsor: Ensoma • Aim: Knowledge-focused
Last updated May 26, 2026 11:33 UTC
-
Major study aims to unlock secrets of rare immune diseases
Knowledge-focused Recruiting nowThis study is for people with immune system problems that cause frequent infections or inflammation, including rare inherited conditions like CGD and XSCID. Researchers will collect medical history, blood, and other samples from up to 3,500 participants (patients, their family me…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 26, 2026 11:09 UTC